+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
MALE
Healthy Volunteers
ID06152497

Investigating How Histamine Affects Muscle Growth and Strength After 10 Weeks of Resistance Training in Men Aged 18 to 45

Led by University Ghent · Updated on 2023-12-13

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how blocking histamine H1 receptors affects muscle growth and strength improvements after ten weeks of resistance training. This study aims to understand how histamine H1 signaling influences adaptations in human skeletal muscle during chronic endurance training. The results will provide insights into the molecular mechanisms behind exercise training adaptations. Participants will be randomly assigned to one of two groups one receiving an oral placebo and the other receiving 180mg of Fexofenadine Telfast to block histamine H1 receptors. Both groups will engage in resistance training focused on lower body exercises for ten weeks. The study uses a triple-blind design to assess how these treatments impact muscle and metabolic responses. During the study, researchers will measure muscle volume, strength on leg press, bench press, bicep curl, and leg curl exercises, as well as muscle fiber growth from biopsies before and after training. They will also evaluate whole-body glucose metabolism using an oral glucose tolerance test and assess vascular function through blood flow measurements. Additional monitoring includes blood pressure and resting heart rate. The study includes healthy male participants aged 18 to 45 and lasts for the duration of the ten-week training period.

CONDITIONS

Brief Title

The Role of Histamine in Muscle Protein Synthesis Following Resistance Training

Research Team

W

Wim Derave, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here